Order Article Reprints

Marconato L, Tiraboschi L, Aralla M, Sabattini S, Melacarne A, Agnoli C, Balboni A, Salvi M, Foglia A, Punzi S, et al. A Phase 2, Single-Arm, Open-Label Clinical Trial on Adjuvant Peptide-Based Vaccination in Dogs with Aggressive Hemangiosarcoma Undergoing Surgery and Chemotherapy. Cancers. 2023; 15(17):4209. https://doi.org/10.3390/cancers15174209

Marconato, Laura, Luca Tiraboschi, Marina Aralla, Silvia Sabattini, Alessia Melacarne, Chiara Agnoli, Andrea Balboni, Marta Salvi, Armando Foglia, Sofia Punzi, and et al. 2023. "A Phase 2, Single-Arm, Open-Label Clinical Trial on Adjuvant Peptide-Based Vaccination in Dogs with Aggressive Hemangiosarcoma Undergoing Surgery and Chemotherapy" Cancers 15, no. 17: 4209. https://doi.org/10.3390/cancers15174209

Marconato, L., Tiraboschi, L., Aralla, M., Sabattini, S., Melacarne, A., Agnoli, C., Balboni, A., Salvi, M., Foglia, A., Punzi, S., Romagnoli, N., & Rescigno, M. (2023). A Phase 2, Single-Arm, Open-Label Clinical Trial on Adjuvant Peptide-Based Vaccination in Dogs with Aggressive Hemangiosarcoma Undergoing Surgery and Chemotherapy. Cancers, 15(17), 4209. https://doi.org/10.3390/cancers15174209